Fertility support is an essential part of conception, whether you are just starting out or have been trying for some time. Conceive Plus® is a sperm safe personal lubricant designed to be used by all trying-to-conceive couples whether you have been trying for a while or just started. The patented formulation is the only lubricant to contain both magnesium and calcium ions, Conceive Plus® is scientifically formulated to be safe for sperm motility, sperm viability and does not harm sperm function. Conceive Plus® does not include complex sugars that interfere with the fertilisation process and does not contain a spermicide. Instead, the lubricant is pH balanced to both sperm and fertile cervical fluid.
The unique formula of Conceive Plus® increases pleasure and relieves vaginal dryness. Making the process even more enjoyable and exciting for you and your partner when you are trying to get pregnant.
The unique formulation of Conceive Plus® has been clinically proven to maintain sperm viability, sperm motility and be safe for embryo development, assisting in providing an environment that may increase the likelihood of pregnancy. The data was presented at the 2009 Annual Meeting of the American Society for Reproductive Medicine6 and has been published in the medical journal Fertility and Sterility, volume 92, issue 2.
SASMAR® is a multinational pharmaceutical company with a particular focus on women’s health and family planning. Founded in Sydney, Australia in 2005, the company now has its global headquarters located in Brussels, Belgium. SASMAR® is a manufacturer and major supplier of lubricants to governmental aid organisations in HIV/AIDS prevention and awareness programs in Third World and developing countries. Official supplier of personal lubricants to the United Nations, SASMAR® brands are also sold in over 60 countries.
6 Development of a Novel, Physiologically Important Ca2+ and Mg2+ ion Containing Non-Spermicidal Vaginal Lubricant J. Kurtz1,2,3, E. Willmer1,2, B. Nikolic1,3, and V. Gupta1,4 1Aquatrove Biosciences, Inc., Miami FL; 2 Emmanuel College, Boston MA; 3 Massachusetts General Hospital, Harvard Medical School, Boston MA; 4 Miller School of Medicine, University of Miami, Miami FL Fertility and Sterility, Volume 92, Issue 3, Supplement 1, September 2009, Pages S212-S213